J2 Ventures

J2 Ventures Research

Investment Thesis

J2 Ventures is a Boston-based dual-use technology venture capital firm founded by Alexander Harstrick and Jonathan Bronson PhD. The firm's core thesis is that the most impactful technology companies are those that can simultaneously advance U.S. national security and capture commercial market opportunity. J2 refers to this as "dual-use" investing — backing early-stage founders whose innovations strengthen national security while also serving everyday systems that keep society safer, healthier, and more connected.

The firm draws on decades of experience across government, defense, science, healthcare, and finance. Their team includes a former Defense Innovation Unit official, a retired Air Force Colonel and physician, a former Navy SEAL, a Harvard MBA from the VC and public policy world, and a Columbia-trained AI scientist. This unique combination allows J2 to evaluate technologies through both mission-critical and market-driven lenses.

J2 has built three consecutive oversubscribed funds: Fund I (early-stage ~$50M), Fund II ($150M, closed 2024), and Fund III "Brookhaven Fund" ($250M, closed November 2025). LPs in Brookhaven include JP Morgan, MetLife, Upsher Management, Alpha Leonis Partners, and the State Investment Council of New Mexico. Brookhaven is one of the largest early-stage vehicles dedicated to dual-use technology.

Sector Focus

J2 Ventures invests across four primary domains:

Advanced Computing: Edge AI hardware, chip-scale computing, AI applications, semiconductor manufacturing, computer vision, and defense-focused AI tooling. Portfolio examples include Femtosense (hyper-efficient edge AI chips), MesaQuantum (chip-scale quantum sensing), Paravision (mission-critical computer vision), and Code Metal (AI for defense-critical industries).

Biomedical Engineering: Next-generation medical devices, wearable health technology, drug discovery, surgical innovation, and bio-manufactured materials. Portfolio examples include Oura Ring (clinical-grade wearables), Tasso (needle-free blood testing), Empress Therapeutics (in-vivo drug discovery), and Safi (bio-manufactured human blood).

Cybersecurity: AI-driven cyber defense, deception technology, trust and safety, software supply chain security, identity and authentication. Portfolio examples include Unit 221B (military-grade threat intelligence), Acalvio (deception and identification), Cinder (unified trust and safety platform), and Kusari (open source software security).

Communications and Infrastructure: Satellite communications, 5G digital cores, critical minerals, satellite imagery, and defense connectivity. Portfolio examples include Aalyria (Google spinout delivering laser-fast internet at planetary scale, valued at $1.3B in 2026), Apex Space (mass-produced small satellites), Druid Software (5G digital cores), and Principal Mineral (critical minerals for US resilience).

The Brookhaven Fund (Fund III) adds explicit emphasis on Artificial Intelligence across sectors and Healthcare with an emphasis on remote physiological monitoring.

Stage Focus

J2 Ventures invests primarily at Pre-Seed, Seed, and Series A. They explicitly state they provide the most value at the beginning of a company's life and collaborate closely with founders from inception. They occasionally make follow-on investments in later rounds for existing portfolio companies, but their entry point is consistently early-stage.

Check Size

Based on observed investments and the $250M Brookhaven Fund deployed across 35+ portfolio companies, typical initial check is estimated at $1M–$10M at Seed and Series A, with reserves for follow-on. Flashpass Education raised $4.25M Seed (April 2026), Musubi raised $5M Seed (February 2025), Druid Software raised $20M (January 2025). These data points suggest J2 writes initial checks in the $1M–$5M range and participates in larger rounds for follow-ons.

Lead Tendency

J2 Ventures typically leads or co-leads early rounds, often writing the first institutional check into portfolio companies. Per their own communications, they wrote "the first institutional check into Sazabi." Their philosophy emphasizes being deeply integrated partners rather than passive investors.

Recent Activity

J2 is actively deploying from Brookhaven Fund (Fund III, $250M, closed November 2025):

• July 2026: Arkenstone Defense (HR systems for dual-use companies)
• April 2026: Flashpass Education raised $4.25M Seed — gov-tech upskilling platform
• March 2026: Alex Harstrick on CNBC discussing AI-driven warfare
• February 2026: Portfolio company Aalyria valued at $1.3 billion in $100M connectivity round
• February 2026: Portfolio company Code Metal raised $125M Series B for defense AI
• November 2025: Brookhaven Fund III closed at $250M (oversubscribed)
• March 2025: Alex Harstrick on CNBC recommending government use Signal for secure comms
• February 2025: Portfolio company Musubi raised $5M Seed (AI content moderation)
• January 2025: Portfolio company Druid Software raised $20M for private 5G in defense and utilities
• 2025: Micron Biomedical extended Series A to $33M+ for needle-free therapeutics

J2-backed companies have raised more than $1 billion in follow-on capital. On average, J2-backed companies raise $2 in non-dilutive government funding for every $1 J2 invests — a unique advantage driven by the team's deep DoD relationships.

Portfolio Highlights

• Oura Ring — Clinical-grade sleep and wellness wearable; one of the most recognized consumer health devices globally
• Aalyria — Google spinout delivering resilient global connectivity networks; valued at $1.3B (February 2026) in a $100M funding round
• Code Metal — AI translation for defense and critical industries; raised $125M Series B (February 2026)
• Apex Space — Mass-produced small satellites accelerating space infrastructure
• MesaQuantum — Industrial-grade atomic clocks powering next-generation communications
• Tasso — Needle-free blood testing used in remote/field settings
• Unit 221B — Military-grade threat intelligence and response
• Acalvio — Leading edge deception technology for cyber defense
• Femtosense — Hyper-efficient edge AI compute chips

The full portfolio spans 37 companies across Advanced Computing (9), Biomedical Engineering (10), Cybersecurity (8), and Infrastructure/Communications (10).

Team

• Alexander Harstrick, Managing Partner & Co-Founder — Former healthcare consultant at Booz & Company, venture capitalist at Blue Cross Blue Shield of New Jersey (launched payers fund), US Army Reserve intelligence officer deployed to Afghanistan and Iraq, Defense Innovation Unit (DIU) investment practice leader (deployed nearly $2B in defense funding), brief stint at KKR. MBA Harvard Business School; BA Hispanic Studies and Political Science, Columbia University. LinkedIn: linkedin.com/in/alexanderharstrick

• Jonathan Bronson, PhD, Managing Partner & Co-Founder — Former Boston Consulting Group consultant (Fortune 500 healthcare, financial services, industrials), COO of health tech startup Backpack Health, renewable energy developer at D.E. Shaw Renewable Investments. Columbia University PhD (AI tools for biochemistry analysis, supported by NSF Graduate Research Fellowship). BA Biochemistry, University of Pennsylvania (Goldwater Scholar).

• Matthew Goldman, MD, Partner — Founding Chief Medical Officer of Defense Innovation Unit (DIU), retired US Air Force Colonel. Practicing physician at Johns Hopkins Health System and Stanford Children's Health (Clinical Assistant Professor of Pediatric Gastroenterology). NATO personalized medicine and performance subcommittee member. MD Medical College of Ohio; residency David Grant Medical Center; fellowship Walter Reed Army Medical Center; BA Molecular Biology, Kenyon College.

• Christine Keung, Partner — Former Chief Data Officer for City of San Jose, early Dropbox security team member (Chief of Staff overseeing legal, policy, security). Launched Paycheck Protection Program at US Small Business Administration ($800B deployed). Former roles at Figma, Bridgewater Associates, Atomic VC, single family office. MBA Harvard Business School; BA Economics, Wellesley College.

• Adam Briley, Director of Federal Solutions — 24-year Navy SEAL career, former Senior VP of Innovation and Applied Research at Naval Special Warfare. CEO and Founder of Atlas Arc Advisors. Cultivates DoD relationships and helps portfolio companies navigate defense procurement. MBA candidate Duke University Fuqua School of Business.

Advisory Board Highlights:

• LTG (ret.) Patricia D. Horoho — Former US Army Surgeon General, former CEO of UnitedHealthcare veteran business
• Jennifer Cable — President of Thor Labs, one of the largest deep tech manufacturing companies in America
• Paul Gompers, PhD — Most published expert on Venture Capital at Harvard Business School
• Raquel Bono, MD — Former senior military healthcare leader
• Geoff Orazem, JD — Policy and legal expert

Geographic Focus

J2 Ventures is headquartered in Boston, MA with a US-wide investment mandate. The firm has particularly strong relationships in the defense and government ecosystem (Pentagon, DIU, DoD, intelligence community) as well as commercial tech hubs.

Decision Process

J2 operates as a multi-partner firm with 5 investment professionals and a deep advisory board. Their stated philosophy emphasizes deep diligence: "We only invest when we know the product, the market, and how to help founders grow their business." The team's complementary expertise across defense, healthcare, technology, and policy enables thorough evaluation of dual-use opportunities.

Founder Preferences

J2 explicitly seeks founders building technologies that can advance both national security and commercial markets simultaneously. They favor technical founders who understand government procurement, can access non-dilutive funding, and are mission-driven toward making the world brighter, safer, and healthier. They act as deeply integrated partners, described by founders as "true partners who act as integrated members of our team and force multipliers."